Abstract
Currently-used rodent tumor models, including transgenic tumor models, or subcutaneously growing human tumors in immunodeficient mice, do not sufficiently represent clinical-cancer, especially with regard to metastasis and drug sensitivity. In order to obtain clinically-accurate models, we have developed the technique of surgical orthotopic implantation (SOI) to transplant histologically intact fragments of human cancer, including tumors taken directly from the patient, to the corresponding organ of immunodeficient rodents. It has been demonstrated in approx 100 publications describing 10 tumor types that SOI allows the growth and metastatic potential of the transplanted tumors to be expressed and reflect clinical cancer. These clinically-accurate and rel evant SOI models of human cancer have enabled discovery and evaluation of novel antitumor and antimetastatic agents including antiangiogenic drugs. The green fluorescent protein (GFP) and red fluorescent protein (RFP) genes, cloned from bioluminescent organisms, have now been introduced into a series of human and rodent cancer cell lines in vitro to stably express GFP and RFP in vivo in SOI mouse models. With these fluorescent tools, tumors and metastasis in host organs can be externally imaged down to the single-cell level. The combination of fluorescent protein-based imaging in SOI models enables real-time antitumor, antimetastatic, and antian giogenic drug evaluation including high-throughput in vivo screening. These SOI models are uniquely useful for innovative drug discovery and mechanism studies and serve as a bridge link ing preclinical and clinical drug development.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fu, X., Besterman, J. M., Monosov, A., and Hoffman, R. M. (1991) Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically-intact patient specimens. Proc. Natl. Acad. Sci. USA 88, 9345–9349.
Fu, X., Theodorescu, D., Kerbel, R. S., and Hoffman, R. M. (1991) Extensive multi-organ metastasis following orthotopic onplantation of histologically-intact human bladder carcinoma tissue in nude mice. Int. J. Cancer 49, 938–939.
Fu, X. and Hoffman, R. M. (1992) Human RT-4 bladder carcinoma is highly metastatic in nude mice and comparable to ras-H-transformed RT-4 when ortho topically onplanted as histologically-intact tissue. Int. J. Cancer 51, 989–991.
Wang, X., Fu, X., and Hoffman, R. M. (1992) A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoraco tomy in immunodeficient mice. Int. J. Cancer 51, 992–995.
Fu, X., Guadagni, F., and Hoffman, R. M. (1992) A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically from histologically-intact patient specimens. Proc. Natl. Acad. Sci. USA 89, 5645–5649.
Hoffman, R. M. (1992) Patient-like models of human cancer in mice. Curr. Per spect. Mol. Cell. Oncol. 1(B) 311–326.
Kuo, T.-H., Kubota, T., Watanabe, M., et al. (1992) Orthotopic reconstitution of human small-cell lung carcinoma after intravenous transplantation in SCID mice. Anticancer Res. 12, 1407–1410.
Fu, X., Herrera, H., Kubota, T., and Hoffman, R. M. (1992) Extensive liver metasta sis from human colon cancer in nude and scid mice after orthotopic onplantation of histologically-intact human colon carcinoma tissue. Anticancer Res. 12, 1395–1398.
Wang, X., Fu, X., and Hoffman, R. M. (1992) A patient-like metastasizing model of human lung adenocarcinoma constructed via thoracotomy in nude mice. Anti cancer Res. 12, 1399–1402.
Wang, X., Fu, X., Kubota, T., and Hoffman, R. M. (1992) A new patient-like metastatic model of human small-cell lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Anticancer Res. 12, 1403–1406.
Fu, X., Herrera, H., and Hoffman, R. M. (1992) Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int. J. Cancer 52, 987–990.
Hoffman, R. M. (1992) Histoculture and the immunodeficient mouse come to the cancer clinic: rational approaches to individualizing cancer therapy and new drug evaluation (Review). Int. J. Oncol. 1, 467–474.
Furukawa, T., Fu, X., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman, R. M. (1993) Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically-intact tissue. Cancer Res. 53, 1204–1208.
Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., Fu, X., and Hoffman, R. M. (1993) Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and indi vidual patient donors. Int. J. Cancer 53, 608–612.
Fu, X. and Hoffman, R. M. (1993) Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res. 13, 283–286.
Furukawa, T., Kubota, T., Watanabe, M., et al. (1993) Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histolog ically-intact tumor tissue in nude mice. Anticancer Res. 13, 287–291.
Kuo, T.-H., Kubota, T., Watanabe, M., et al. (1993) Early resection of primary orthotopically-growing human colon tumor in nude mouse prevents liver metasta sis: further evidence for patient-like hematogenous metastatic route. Anticancer Res. 13, 293–297.
Furukawa, T., Kubota, T., Watanabe, M., Kuo, T. H., Kitajima, M., and Hoffman, R. M. (1993) Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically-intact tumor tissue in nude mice. Int. J. Cancer 54, 397–401.
Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman, R. M. (1993) A novel “patient-like” treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically-intact human tumor-tissue in nude mice. Cancer Res. 53, 3070–3072.
Kuo, T.-H., Kubota, T., Watanabe, M., et al. (1993) Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcuta neously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res. 13, 627–630.
Furukawa, T., Kubota, T., Watanabe, M., et al. (1993) A metastatic model of human colon cancer constructed using cecal implantation of cancer tissue in nude mice. Jpn. J. Surg. 23, 420–423.
Fu, X., Le, P., and Hoffman, R. M. (1993) A metastatic orthotopic transplant nude mouse model of human patient breast cancer. Anticancer Res. 13, 901–904.
Astoul, P., Colt, H. G., Wang, X., and Hoffman, R. M. (1993) Metastatic human pleural ovarian cancer model constructed by orthotopic implantation of fresh his tologically-intact patient carcinoma in nude mice. Anticancer Res. 13, 1999–2002.
Astoul, P., Wang, X., and Hoffman, R. M. (1993) “Patient-like” nude and SCID-mouse models of human lung and pleural cancer (Review). Int. J. Oncol. 3, 713–718.
Kubota, T., Inoue, S., Furukawa, T., et al. (1993) Similarity of serum-tumor phar macokinetics of antitumor agents in man and nude mice. Anticancer Res. 13, 1481–1484.
Astoul, P., Colt, H. G., Wang, X., and Hoffman, R. M. (1994) A “patient-like” nude mouse model of parietal pleural human lung adenocarcinoma. Anticancer Res. 14, 85–92.
Astoul, P., Colt, H. G., Wang, X., et al. (1994) A “patient-like” nude mouse metastatic model of advanced human pleural cancer. J. Cell Bichem. 56, 9–15.
Wang, X., Fu, X., Brown, P. D., Crimmin, M. J., and Hoffman, R. M. (1994) Matrix metalloproteinase inhibitor BB-95 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54, 4726–4728.
Hoffman, R. M. (1994) Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models? J. Cell Biochem. 56, 1–3.
Togo, S., Shimada, H., Kubota, T., Moossa, A. R., and Hoffman, R. M. (1995) Seed to soil is a return trip in metastasis. Anticancer Res. 15, 791–794.
Togo, S., Shimada, H., Kubota, T., Moossa, A. R., and Hoffman, R. M. (1995) Host organ specifically determines cancer progression. Cancer Res. 55, 681–684.
Kuo, T.-H., Kubota, T., Watanabe, M., et al. (1995) Liver colonization competence governs colon cancer metastasis. Proc. Natl. Acad. Sci. USA 92, 12,085–12,089.
Togo, S., Wang, X., Shimada, H., Moossa, A. R., and Hoffman, R. M. (1995) Cancer seed and soil can be highly selective: human-patient colon tumor lung metastasis grows in nude mouse lung but not colon or subcutis. Anticancer Res. 15, 795–798.
Dutton, G. (1996) AntiCancer Inc. scientists identify a key governing step in the metastasis of cancer. Genet. Eng. News 16, 1, January 15.
Holzman, D. (1996) Of mice and metastasis: a new for-profit model emerges. J. Natl. Cancer Inst. 88, 396–397.
Leff, D. N. (1996) MetaMouse models colon cancer metastasis with clinical poten tial. BioWorld Today 7, 1, January 8.
Sun, F. X., Tang, Z. Y., Liu, K. D., et al. (1996) Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int. J. Cancer 66, 239–243.
An, Z., Wang, X., Kubota, T., Moossa, A. R., and Hoffman, R. M. (1996) A clin ical nude mouse metastatic model for highly malignant human pancreatic cancer. Anticancer Res. 16, 627–631.
Riordan, T. (1996) A technique is said to ease attachment of tumors to mice, making them little cancer patients. The New York Times, Patents Column, March 4. 40. Murray, G., Duncan, M., O'Neil, P., Melvin, W., Fothergill, J. (1996) Matrix met alloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2, 461–462.
Hoffman, R. M. (1996) Fertile seed and rich soil: development of patient-like models of human cancer by surgical orthotopic implantation of intact tissue, in Update Series: Comprehensive Textbook of Oncology (Schimpff, S. C., et al., eds.), Williams & Wilkins, Baltimore, vol. 3, pp. 1–10.
Sun, F.-X., Tang, Z.-Y., Liu, K.-D., et al. (1996) Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens. J. Cancer Res. Clin. Oncol. 122, 397–402.
Astoul, P., Wang, X., Colt, H. G., Boutin, C., and Hoffman, R. M. (1996) A patient-like human malignant pleural mesothelioma nude-mouse model. Oncol. Rep. 3, 483–487.
Colt, H. G., Astoul, P., Wang, X., Yi, E. S., Boutin, C., and Hoffman, R. M. (1996) Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model. Anticancer Res. 16, 633–639.
An, Z., Wang, X., Astoul, P., Danays, T., and Hoffman, R. M. (1996) Interferon gamma is highly effective against orthotopically-implanted human pleural adeno carcinoma in nude mice. Anticancer Res. 16, 2545–2551.
Kamiyama, M., Ichikawa, Y., Ishikawa, T., et al. (2002) VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice. Cancer Gene Ther. 9, 197–201.
An, Z., Wang, X., Willmott, N., et al. (1997) Conversion of highly malignant colon cancer from an aggesssive to a controlled disease by oral administration of a met alloproteinase inhibitor. Clin. Exp. Metastasis 15, 184–195.
Hoffman, R. M. (1997) Fertile seed and rich soil: the development of clinically rel evant models of human cancer by surgical orthotopic implantation of intact tissue, in Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Teicher, B., ed.), Humana, Totowa, NJ, pp. 127–144.
Chishima, T., Miyagi, Y., Wang, X., et al. (1997) Cancer invasion and micrometas tasis visualized in live tissue by green fluorescent protein expression. Cancer Res. 57, 2042–2047.
Inada, T., Ichikawa, A., Kubota, T., Ogata, Y., Moossa, A R., and Hoffman, R. M. (1997) 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res. 17, 1965–1972.
Chishima, T., Miyagi, Y., Wang, X., et al. (1997) Metastatic patterns of lung cancer visualized live and in process by green fluorescent protein expression. Clin. Exp. Metastasis 15, 547–552.
Chishima, T., Miyagi, Y., Wang, X., et al. (1997) Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res. 17, 2377–2384.
Chishima, T., Yang, M., Miyagi, Y., et al. (1997) Governing step of metastasis visualized in vitro. Proc. Natl. Acad. Sci. USA 94, 11,573–11,576.
Tomikawa, M., Kubota, T., Matsuzaki, S. W., et al. (1997) Mitomycin C and cisplatin increase survival in a human pancreatic cancer metastatic model. Anticancer Res. 17, 3623–3626.
Chishima, T., Miyagi, Y., Li, L., et al. (1997) The use of histoculture and green fluorescent protein to visualize tumor cell host interaction. In Vitro Cell. Dev. Biol. 33, 745–747.
Chang, S.-G., Kim, J. I., Jung, J.-C., et al. (1997) Antimetastatic activity of the new platinum analog (cis-dach)(DPPE). (2NO 3 in a metastatic model of human bladder cancer. Anticancer Res. 17, 3239–3242.
Dev, S. B., Nanda, G. S., An, Z., Wang, X., Hoffman, R. M, and Hofmann, G. A. (1997) Effective electroporation therapy of human pancreatic tumors implanted in nude mice. Drug Delivery 4, 293–299.
An, Z., Wang, X., Geller, J., Moossa, A. R., and Hoffman, R. M. (1998) Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. Prostate 34, 169–174.
Nanda, G. S., Sun, F. X., Hofmann, G. A., Hoffman, R. M., and Dev, S. B. (1998) Electroporation therapy of human larynx tumors HEp-2 implanted in nude mice. Anticancer Res. 18, 999–1004.
Nanda, G. S., Sun, F. X., Hofmann, G. A., Hoffman, R. M., and Dev, S. B. (1998) Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model. Anticancer Res. 18, 1361–1366.
Yang, M., Hasegawa, S., Jiang, P., et al. (1998) Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res. 58, 4217–221.
Sun, F.-X., Sasson, A. R., Jiang, P., An, Z., Gamagami, R., Li, L., Moossa, A. R., and Hoffman, R. H. (1999) An ultra-metastatic model of human colon cancer in nude mice. Clin. Exp. Metastasis 17(1), 41–48.
Kiguchi, K., Kubota, T., Aoki, D., et al. (1998) A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer. Clin. Exp. Metastasis 16, 751–756.
Yang, M., Jiang, P., Sun, F. X., et al. (1999) A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res. 59, 781–786.
Wang, X., An, Z., Geller, J., and Hoffman, R. M. (1999) A high malignancy orthotopic nude mouse model of the human prostate cancer LNCaP. Prostate 39, 182–186.
Kanai, T., Konno, H., Tanaka, T., et al. (1997) Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice. Int. J. Cancer 71, 838–841.
Konno, H., Tanaka, T., Kanai, T., Maruyama, K., Nakamura, S., and Baba, S.(1996) Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential. Cancer 77(8), 1736–1740.
Konno, H., Tanaka, T., Matsuda, I., et al. (1995) Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470 and mitomycin C on the growth and liver metastasis of human colon cancer. Int. J. Cancer 61, 268–271.
Konno, H., Tanaka, T., Baba, M., et al. (1997) Antitumor effect of angiogenesis inhibitors on colon cancer. Biotherapy 11, 993–996.
Tanaka, T., Konno, H., Matsuda, I., Nakamura, S., and Baba, S. (1995) Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res. 55, 836–839.
Konno, H., Arai, T., Tanaka, T., et al. (1998) Antitumor effect of neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm. Jpn. J. Cancer Res. 89, 933–939.
An, Z., Jiang, P., Wang, X., Moossa, A. R., and Hoffman, R. M. (1999) Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin. Exp. Metastasis 17, 265–270.
Rashidi, B., An, Z., Sun, F.-X., et al. (1999) Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice. Clin. Exp. Metastasis 17, 497–500.
Rashidi, B., Gamagami, R., Sasson, A., et al. (2000) An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. Clin. Cancer Res. 6, 2556–2561.
Rashidi, B., An, Z., Sun, F.-X., Moossa, A. R., and Hoffman, R. M. (2000) Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice. Clin. Cancer Res. 6, 2464–2468.
Rho, Y.-S., Lee, K.-T., Jung, J.-C., et al. (1999) Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer. Anticancer Res. 19, 157–162.
Sun, F.-X., Tohgo, A., Bouvet, M., et al. (2003) Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 63, 80–85.
Ohta, M., Konno, H., Tanaka, T., et al. (2001) Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer. Jpn. J. Cancer Res. 92, 688–695.
Oba, K., Konno, H., Tanaka, T., et al. (2002) Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166. Cancer Lett. 175, 45–51.
Tanaka, T., Konno, H., Baba, S., et al. (2001) Prevention of hepatic and peritoneal metastases by the angiogenesis inhibitor fr-118487 after removal of growing tumor in mice. Jpn. J. Cancer Res. 92, 88–94.
Matsumoto, K., Konno, H., Tanaka, T., et al. (2000) Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft. Jpn. J. Cancer Res. 91, 748–752.
Konno, H., Arai, T., Tanaka, T., et al. (1998) Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm. Jpn. J. Cancer Res. 89, 933–939.
Kanai, T., Konno, H., Tanaka, T., et al. (1998) Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. Int. J. Cancer 77, 933–936.
Kanai, T., Konno, H., Tanaka, T., et al. (1997) Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice. Int. J. Cancer 71, 838–841.
Konno, H., Tanaka, T., Kanai, T., Maruyama, K., Nakamura, S., and Baba, S. (1996) Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential. Cancer 77, 1736–1740.
Tanaka, T., Konno, H., Matsuda, I., Nakamura, S., and Baba, S. (1995) Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res. 55, 836–839.
Konno, H., Tanaka, T., Matsuda, I., et al. (1995) Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer. Int. J. Cancer 61, 268–271.
Matsuda, I., Konno, H., Tanaka, T., and Nakamura, S. (2001) Antimetastatic effect of hepatotropic liposomal adriamycin on human metastatic liver tumors. Surg. Today 31, 414–420.
Konno, H., Tanaka, T., Baba, M., et al. (1999) Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma. Jpn. J. Cancer Res. 90, 448–453.
Wang, J.-W., Yang, M., Wang, X., et al. (2003) Antimetastatic efficacy of oral 5-FU imaged by green fluorescent protein in real time. Anticancer Res. 23, 1–6.
Lee, N. C., Bouvet, M., Nardin, S., et al. (2001) Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model. Clin. Exp. Metastasis 18, 379–384.
Katz, M. H., Bouvet, M., Takimoto, S., Spivac, D., Moossa, A. R., and Hoffman, R M. (2003) Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Cancer Res. 63, 5521–5525.
Katz, M. H., Bouvet, M., Takimoto, S., Spivack, D., Moossa, A. R., and Hoffman, R. M. (2004) Survival efficacy of adjuvant cytosine-analog CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Res. 64, 1828–1833.
Wu, M., Mazurchuk, R., Chaudhary, N. D., et al. (2003) High-resolution magnetic resonance imaging of the efficacy of the cytosine analog 1-[2-C-Cyano-2-deoxy-β-D-arabino-pentofuranosyl]-N4-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model. Cancer Res. 63, 2477–2482.
Hoffman, R. (2002) Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol. 3, 546–556.
Yamamoto, N., Yang, M., Jiang, P., et al. (2003) Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging. Cancer Res. 63, 7785–790.
Yang, M., Li, L., Jiang, P., Moossa, A. R., Penman, S., and Hoffman, R. M. (2003) Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc. Natl. Acad. Sci. USA 100, 14,259–14,262.
Yang, M., Baranov, E., Li, X.-M., et al. (2001) Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc. Natl. Acad. Sci. USA 98, 2616–621.
Yang, M., Baranov, E., Wang, J.-W., et al. (2002) Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc. Natl. Acad. Sci. USA 99, 3824–3829.
Hoffman, R. M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs 17, 343–359.
Katz, M., Takimoto, S., Spivac, D., Moossa, A. R., Hoffman, R. M., and Bouvet, M. (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J. Surg. Res. 113, 151–160.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Hoffman, R.M. (2005). Orthotopic Metastatic (MetaMouse®) Models for Discovery and Development of Novel Chemotherapy. In: Blumenthal, R.D. (eds) Chemosensitivity: Volume II. Methods in Molecular Medicine™, vol 111. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-889-7:297
Download citation
DOI: https://doi.org/10.1385/1-59259-889-7:297
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-586-6
Online ISBN: 978-1-59259-889-2
eBook Packages: Springer Protocols